Aerie Pharmaceuticals to Present at Three Investor Conferences in March

IRVINE, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (Nasdaq: AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, today announced that company management will present at the following conferences in March. Cowen and Company 37th Annual Health Care Conference Presenter: Vicente Anido, Jr., Ph.D., Chairman and Chief Executive Officer Presentation